Alan B. Sandler
Chief Development Officer; Director · 3 filings · Latest: Sep 29, 2026
ALX ONCOLOGY HOLDINGS INC
Revolution Medicines, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RVMD | Alan B. Sandler | Chief Development Officer | Sep 29, 2026 | Sale | $202.14 | 6,309 | $1.3M | 52,559 | |
RVMD | Alan B. Sandler | Chief Development Officer | Sep 29, 2026 | Option Exercise | $58.84 | 6,000 | $353.0K | 58,868 | |
RVMD | ALAN SANDLER | — | Sep 29, 2026 | Proposed Sale | $201.74 | 6,309 | $1.3M | — | |
RVMD | Alan B. Sandler | Chief Development Officer | Sep 16, 2026 | Sale | $199.24 | 341 | $67.9K | 52,868 | |
RVMD | Sandler Alan B | — | Sep 15, 2026 | Proposed Sale | $203.77 | 331 | $67.4K | — |